Alphatec Holdings (Alphatec Holdings) Research & Development : $70.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Alphatec Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alphatec Holdings's Research & Development for the three months ended in Dec. 2023 was $22.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $70.1 Mil.

Alphatec Holdings Research & Development Historical Data

The historical data trend for Alphatec Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alphatec Holdings Research & Development Chart

Alphatec Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

13.85

18.75

32.02

44.03

70.12

Alphatec Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															11.60	13.26	14.57	20.00	22.28

Alphatec Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $70.1 Mil.

Alphatec Holdings (NAS:ATEC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alphatec Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Alphatec Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Alphatec Holdings (Alphatec Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Alphatec Holdings Inc (NAS:ATEC) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

L1Z1:Germany

Address

1950 Camino Vida Roble, Carlsbad, CA, USA, 92008

Website

https://www.atecspine.com

Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.

Executives

David Sponsel	officer: EVP, Sales	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
David M Demski	director	C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Patrick Miles	director, officer: Executive Chairman	7475 LUSK BLVD., SAN DIEGO CA 92121
Tullis James L L	director, 10 percent owner	100 FIRST STAMFORD PLACE, STAMFORD CT 06907
David H Mowry	director	9775 TOLEDO, IRVINE CA 92618
Evan Bakst	director	225 CENTRAL PARK WEST, APT. 1605, NEW YORK NY 10024
Jennifer N. Pritzker	10 percent owner	C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Tyson Eliot Marshall	officer: GENERAL COUNSEL & CORP. SEC.	10680 TREENA STREET, SUITE 500, SAN DIEGO CA 92131
Craig E Hunsaker	officer: See Remarks	C/O ALPHATEC HOLDINGS, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Paul Segal	10 percent owner	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
L-5 Healthcare Partners, Llc	10 percent owner, other: Director by deputization	1700 BROADWAY, 35TH FLOOR, NEW YORK NY 10019
John Todd Koning	officer: Chief Financial Officer	C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
David R Pelizzon	director, 10 percent owner	2850 FRONTIER DR, WARSAW IN 46582
Scott Lish	officer: SVP, Development	C/O ALPHATEC SPINE, INC., 5818 EL CAMINO REAL, CARLSBAD CA 92008